Peripheral Neuropathy Trial, Recruiting (NCT07038239)

Peripheral Neuropathy Trial, Recruiting NCT07038239 Sponsor: Hospices Civils de Lyon Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT07038239 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have a change (mutation) in a gene called MORC2, which was found during testing for nerve problems or intellectual disability
People who have already had, or are able to have, a nerve conduction and muscle activity test (called an EMG) at the time of joining the trial
People who are covered by the national health insurance system in France
Adults who are able to give their own consent to participate, or children whose parents or legal guardians are able to give consent on their behalf

Who may not be able to join:

People who have another gene mutation that is known to cause nerve problems or intellectual disability
People who are not willing to have biological samples (such as blood) collected as part of the trial
Women who are currently pregnant, have recently given birth, or are breastfeeding
People who are currently held in custody or detained by a legal or government decision
People who are not covered by a social security or equivalent health coverage scheme

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00334 72 07 25 73

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07038239

Sponsor: Hospices Civils de Lyon

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: 00334 72 07 25 73

More information: https://clinicaltrials.gov/study/NCT07038239

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have a change (mutation) in a gene called MORC2, which was found during testing for nerve problems or intellectual disability
People who have already had, or are able to have, a nerve conduction and muscle activity test (called an EMG) at the time of joining the trial
People who are covered by the national health insurance system in France
Adults who are able to give their own consent to participate, or children whose parents or legal guardians are able to give consent on their behalf

Who may not be able to join:

People who have another gene mutation that is known to cause nerve problems or intellectual disability
People who are not willing to have biological samples (such as blood) collected as part of the trial
Women who are currently pregnant, have recently given birth, or are breastfeeding
People who are currently held in custody or detained by a legal or government decision
People who are not covered by a social security or equivalent health coverage scheme

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hospices Civils de Lyon

Registry

ClinicalTrials.gov

Start date

16 June 2026

Est. completion

1 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Epigenetic biomarker levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov